The purpose of this study is to test a comprehensive, male-oriented, online screening and referral (Screening for Mental Health; SMH) and male-oriented online information and referral intervention program (Man Therapy; MT) to improve mental health and wellbeing with a focus on prevention of suicide and help-seeking behaviors among middle-aged men. The online programs will be offered together to maximize the effect on reducing suicide behavior and increasing mental health help-seeking behaviors for men. If successful in decreasing suicide behavior and ideation and increasing suicide help-seeking behavior, this intervention could be scaled up to contribute to a reduction in suicide behaviors and deaths across the country.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
554
Participants in the Screening for Mental Health (SMH)-only group will complete the online depression and suicide screening and receive immediate feedback and referrals.
Participants assigned to Screening for Mental Health, plus Man Therapy (SMH+MT) group will be offered the Man Therapy program in conjunction with Screening for Mental Health. MT provides online early intervention services designed specifically for men who are at risk for suicide and are less likely to engage in help-seeking behavior. MT takes an innovative and humorous approach to mental health education and help seeking through a fictional "therapist" named Dr. Rich Mahogany, who is a no-nonsense "man's man" who informs men about the importance of honest talk about life's challenges in addressing their problems. The web portal allows review "manly mental health information, facts and tips," explore "man therapies," and view videos of men with lived experience.
University of Maryland Baltimore
Baltimore, Maryland, United States
Change in depression symptoms as measured by The HANDS: Harvard Department of Psychiatry National Depression Screening Day Scale
Time frame: Baseline; 2 weeks post randomization; 12 weeks post randomization
Change in suicide risk as measured by the Columbia-Suicide Severity Rating Scale-Screen Version
Time frame: Baseline; 2 weeks post randomization; 12 weeks post randomization
change in attitudes toward help-seeking behavior as measured by the Attitudes Toward Seeking Professional Help short-form
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in alcohol use/abuse as measured by the Alcohol Use Disorders Identification Test
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in relationship conflicts as measured by the Psychological Aggression Scale
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in financial situation as measured by two items (J1 and J4) of the 2009 National Financial Capability Study, Financial Industry Regulatory Authority
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in social support as measured by the Perceived Social Support and/or Conflict scale
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in interpersonal needs as measured by the Interpersonal Needs Questionnaire
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in drug use/abuse as measured by the National Institute of Drug Abuse Quick Screen
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in physical aggression as measured by the Physical Aggression Index scale
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in help seeking behavior as measured by the Perceived Stigma and Barriers to Care for Psychological Problems scale
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in help seeking behavior as measured by the General Help Seeking Questionnaire
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in physical and mental health as measured by the Healthy Days Measures
Time frame: 2 weeks post randomization; 12 weeks post randomization
change in anger as measures by the DSM-5 Self Rated Level 1 Cross-Cutting Symptom Measure
Time frame: Baseline; 2 weeks post randomization; 12 weeks post randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.